CSE’s Barrington Miller was recently joined in the studio by Dr. Raza Bokhari, CEO of FSD Pharma (CSE:HUGE), whose company recently celebrated their market open at the Canadian Securities Exchange. 

In this discussion Dr. Bokhari shares what it’s like to be the first company to be dual-listed on the CSE and NASDAQ (1:35), the importance for companies in the capital markets to be in “the big ocean” (5:25), the groundbreaking clinical trials FSD Pharma is conducting with a synthetic compound that acts like CBD (6:30), and the “HUGE” importance of their ticker symbol (11:00).

Listen until the end to hear Dr. Bokhari’s personal path towards becoming a serial, “eccentric”, entrepreneur (12:30).

🔴 Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe

#alwaysinvested

STAY CONNECTED WITH THE CSE
=============================

📧 - NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe
🎧 - PODCAST: https://blog.thecse.com/cse-podcasts/
📸 - INSTAGRAM: https://www.instagram.com/canadianexchange/
🤝 - LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
👥 - FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
🐦 - X: https://x.com/CSE_News
📝 - BLOG: https://blog.thecse.com/
🖥 - WEBSITE: https://thecse.com/
📖 - MAGAZINE: https://issuu.com/thecse/docs

©2024 CNSX Markets Inc. All rights reserved.